Skip to content
+49 3371 6199600info@celltrend.deIm Biotechnologiepark 3 TGZ II, 14943 Luckenwalde
  • Contact
  • German
  • English
topbar - English
Search:
Suche
CellTrend Luckenwalde
Auftragsforschung, Antikörperdiagnostik
CellTrend LuckenwaldeCellTrend Luckenwalde
  • Company Profile
    • Newsroom
    • Board of management
    • Quality Management System
    • Referenzen
    • Partners
  • POTS – CFS/ME – SFN – Long Covid
    • Information for patients
  • AT1R-Antibody ELISA
    • Product information
    • Transplantation
    • Systemic sclerosis
    • Literature
  • ELISA
    • GPCR-Antibodies
    • In vitro Diagnostics (human)
    • Research use only
    • Food analysis
    • Contract research
    • Contract manufacturing
  • Consulting
  • Fluorescent Cells
  • Cell culture test systems
    • Oncology
    • Inflammatory test systems
    • Contract research
  • Company Profile
    • Newsroom
    • Board of management
    • Quality Management System
    • Referenzen
    • Partners
  • POTS – CFS/ME – SFN – Long Covid
    • Information for patients
  • AT1R-Antibody ELISA
    • Product information
    • Transplantation
    • Systemic sclerosis
    • Literature
  • ELISA
    • GPCR-Antibodies
    • In vitro Diagnostics (human)
    • Research use only
    • Food analysis
    • Contract research
    • Contract manufacturing
  • Consulting
  • Fluorescent Cells
  • Cell culture test systems
    • Oncology
    • Inflammatory test systems
    • Contract research

Daily Archives: 10. October 2018

You are here:
  1. Home
  2. 2018
  3. October
  4. 10

CellTrend received the European patent for antibodies against EGF (EP 3102945)

NewsBy oderm10. October 2018

The results of the present examples show that anti-EGF antibody levels are significantly lower in patients with ovarian cancer compared to healthy controls. In addition, levels are significantly higher in patients who do not relapse after treatment with panitumumab or chemotherapeutic agents. Levels of anti-EGF antibodies in samples are a well-suited predictor of response to…

+49 3371 6199600 info@celltrend.de Im Biotechnologiepark 3 TGZ II, 14943 Luckenwalde
  • Data protection declaration
  • Imprint
bottombar - English

FacebookInstagram

Go to Top